J C La Rosa, W V Brown, P L Frommer, R I Levy. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh： See more » Anticholesteremic Agents/adverse effectsArrhythmias, Cardiac/chemically inducedCatecholamines/urineCerebellar Ataxia/chemically inducedCreatine Kinase/metabolismDrug SynergismFemaleHumansMiddle AgedMyocardium/enzymologyNystagmus, Pathologic/chemically inducedPhenytoin/therapeutic usePhysical ExertionPotassium/bloodProcainamide/therapeutic usePropranolol/adverse effectsXanthomatosis/drug therapy
Substances： See more » Anticholesteremic AgentsCatecholaminesPhenytoinPropranololCreatine KinaseProcainamidePotassium
Year: 1969 PMID： 5773125 DOI： 10.1016/0002-9149(69)90076-9
Source DB: PubMed Journal: Am J Cardiol ISSN： 0002-9149 Impact factor: 2.778